http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2269629-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea57db10fe6e572d4a54808447081e9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-52
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0639
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-38
filingDate 2001-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd096685a426b0a4fd87293688bed191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_349d1dd10c9d68c815364e48ca020dac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e56a1c9743bcc51cc44dc0ba01e2b45f
publicationDate 2011-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2269629-A2
titleOfInvention Compositions and methods for producing antigen-presenting cells
abstract The present invention relates to compositions and methods for producing antigen-presenting cells, in vitro, ex vivo or in vivo. This invention relates more particularly to methods and compositions for producing dendritic cells using interleukin-15, preferably in combination with a growth factor such as GM-CSF. This invention is particularly suited for producing immature dendritic cells and activated cells from precursors, in vitro, ex vivo or in vivo. The invention also relates to compositions for implementing these methods, as well as compositions comprising antigen-presenting cells and uses thereof. Dendritic cells or membrane vesicles derived thereforom have utility in many applications, including diagnostic, therapy, vaccination, research, screening and gene delivery.
priorityDate 2000-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5747024-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9903499-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129019219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129881422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525

Total number of triples: 43.